Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management

L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - Am Heart Assoc
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega‐Paz, D Capodanno, G Montalescot… - Journal of the American …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p xml: lang=" en"> Coronavirus disease 2019
(COVID‐19) is an infectious disease caused by severe acute respiratory syndrome …

[PDF][PDF] Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno, G Montalescot… - 2020 - pedago.cl
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus-2, which has posed a significant threat to global health …

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno… - Journal of the …, 2020 - europepmc.org
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management.

L Ortega-Paz, D Capodanno, G Montalescot… - 2020 - cabidigitallibrary.org
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus-2, which has posed a significant threat to global …

[HTML][HTML] Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus-2, which has posed a significant threat to global health …

[PDF][PDF] Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno, G Montalescot… - 2020 - pdfs.semanticscholar.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus-2, which has posed a significant threat to global health …

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno… - Journal of the …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus-2, which has posed a significant threat to global health …

Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic …

L Ortega-Paz, D Capodanno… - Journal of the …, 2020 - europepmc.org
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …